EP2863228 - Method for diagnosis of primary hyperaldosteronism [Right-click to bookmark this link] | Status | The application has been refused Status updated on 03.06.2016 Database last updated on 19.10.2024 | Most recent event Tooltip | 03.06.2016 | Refusal of application | published on 06.07.2016 [2016/27] | Applicant(s) | For all designated states Attoquant Diagnostics GmbH Campus-Vienna-Biocenter 5 1030 Vienna / AT | [2015/17] | Representative(s) | SONN Patentanwälte GmbH & Co KG Riemergasse 14 1010 Wien / AT | [N/P] |
Former [2015/17] | Sonn & Partner Patentanwälte Riemergasse 14 A-1010 Wien / AT | Application number, filing date | 13189386.9 | 18.10.2013 | [2015/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2863228 | Date: | 22.04.2015 | Language: | EN | [2015/17] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.12.2013 | Classification | IPC: | G01N33/74 | [2015/17] | CPC: |
G01N33/743 (EP);
G01N33/6893 (EP);
G01N2800/04 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/17] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Verfahren zur Diagnose von primärem Hyperaldosteronismus | [2015/17] | English: | Method for diagnosis of primary hyperaldosteronism | [2015/17] | French: | Procédé de diagnostic d'hyperaldostéronisme primaire | [2015/17] | Examination procedure | 18.10.2013 | Examination requested [2015/17] | 30.04.2015 | Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2016/27] | 10.05.2015 | Application refused, date of legal effect [2016/27] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.10.2015 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] - KATO M ET AL, "Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure", JOURNAL OF CARDIAL FAILURE, CHURCHILL LIVINGSTONE, NAPERVILLE, IL, US, (19960601), vol. 2, no. 2, doi:10.1016/S1071-9164(96)80028-5, ISSN 1071-9164, pages 103 - 110, XP004680556 [X] 12,13,15 * abstract * [I] 14 DOI: http://dx.doi.org/10.1016/S1071-9164(96)80028-5 | [XA] - LIM PITT O ET AL, "The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?", JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, LTD, US / UK, (20020101), vol. 20, no. 1, ISSN 0263-6352, pages 11 - 15, XP009174679 [X] 1 * abstract * * page 13, column l, paragraph 1; figure 2 * [A] 2-15 DOI: http://dx.doi.org/10.1097/00004872-200201000-00003 | [XI] - WISGERHOF M ET AL, "Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (19781101), vol. 47, no. 5, ISSN 0021-972X, pages 938 - 943, XP009174704 [X] 1,2,4,6,8,9,11,12,15 * abstract * * page 942, column r, paragraph l * [I] 3,5,7,10,13,14 DOI: http://dx.doi.org/10.1210/jcem-47-5-938 | [A] - MCKENNA T J ET AL, "Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (19911101), vol. 73, no. 5, ISSN 0021-972X, pages 952 - 957, XP009174678 [A] 1-15 * abstract * DOI: http://dx.doi.org/10.1210/jcem-73-5-952 | by applicant | WO03016861 | - TIU S; CHOI C; SHEK C; NG Y; CHAN F; NG C; KONG A, "The use of aldosterone-renin ratio as a diagnostic test for prima- ry hyperaldosteronism and its test characteristics under different conditions of blood sampling", J CLIN ENDOCRINOL METAB, (2005), vol. 90, no. 1, page 8 | - JOHN W. FUNDER ET AL., J CLIN ENDOCRINOL METAB., (200809), vol. 93, no. 9, pages 3266 - 3281 | - GARY L. SCHWARTZ; STEPHEN T. TURNER, CLINI- CAL CHEMISTRY, (2005), vol. 51, no. 2 | - SWALES JD; THURSTON HJ, CLIN ENDOCRINOL METAB., (197707), vol. 45, no. 1, pages 159 - 63 | - BYSTROM ET AL., CLIN. CHEM., (2010), vol. 56, pages 1561 - 1569 | - GARY L. SCHWARTZ; STEPHEN T. TURNER, CLINICAL CHEMISTRY, (2005), vol. 51, no. 2 | - CUI ET AL., ANAL BIOCHEM., (2007), vol. 369, pages 27 - 33 | WO2012EP60678 |